KR100570446B1 - 산 불안정성 약리활성물질 함유 장용성 경구용 제제 및 이의 제조방법 - Google Patents
산 불안정성 약리활성물질 함유 장용성 경구용 제제 및 이의 제조방법 Download PDFInfo
- Publication number
- KR100570446B1 KR100570446B1 KR1020050012104A KR20050012104A KR100570446B1 KR 100570446 B1 KR100570446 B1 KR 100570446B1 KR 1020050012104 A KR1020050012104 A KR 1020050012104A KR 20050012104 A KR20050012104 A KR 20050012104A KR 100570446 B1 KR100570446 B1 KR 100570446B1
- Authority
- KR
- South Korea
- Prior art keywords
- enteric
- core
- enteric coating
- pantoprazole
- coating layer
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47G—HOUSEHOLD OR TABLE EQUIPMENT
- A47G1/00—Mirrors; Picture frames or the like, e.g. provided with heating, lighting or ventilating means
- A47G1/06—Picture frames
- A47G1/0616—Ornamental frames, e.g. with illumination, speakers or decorative features
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47B—TABLES; DESKS; OFFICE FURNITURE; CABINETS; DRAWERS; GENERAL DETAILS OF FURNITURE
- A47B2200/00—General construction of tables or desks
- A47B2200/14—Aquarium table
Abstract
Description
Claims (11)
- 삭제
- 삭제
- 약리학적 활성물질로서 판토프라졸 나트륨염을 함유하는 코어와 장용성 고분자 및 필수적으로 가소제로서 폴리에틸렌글리콜을 함유하는 장용성 코팅층을 가지며, 상기 코어에 장용성 코팅층을 직접 피복시킨 판토프라졸 함유 경구용 제제.
- 삭제
- 제 3 항에 있어서, 결합제로서 저점도 히드록시프로필메틸셀룰로오스, 부형제로서 유당, 붕해제로서 크로스포비돈을 포함하는 코어인 것을 특징으로 하는 판토프라졸 함유 경구용 제제.
- 삭제
- 제 3 항에 있어서, 장용성 고분자는 메타크릴산 공중합체임을 특징으로 하는 판토프라졸 함유 경구용 제제.
- 약리학적 활성물질로서 판토프라졸 나트륨염을 함유하는 코어를 제조하는 단계;장용성 고분자 및 필수적으로 가소제로서 폴리에틸렌글리콜을 용매에 용해 또는 현탁시켜 장용성 현탁액을 제조하는 단계; 및상기 코어에 상기 장용성 현탁액을 분무시켜 장용성 코팅층을 형성하는 단계로 이루어지되, 코어와 장용성 코팅층 사이에 별도의 피막이 생성되지 않는 판토프라졸 함유 경구용 제제의 제조방법.
- 삭제
- 제 8 항에 있어서, 결합제로서 저점도 히드록시프로필메틸셀룰로오스, 부형제로서 유당, 붕해제로서 크로스포비돈을 포함하는 코어인 것을 특징으로 하는 판토프라졸 함유 장용성 경구용 제제의 제조방법.
- 제 8 항에 있어서, 장용성 고분자는 메타크릴산 공중합체임을 특징으로 하는 판토프라졸 함유 장용성 경구용 제제의 제조방법.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050012104A KR100570446B1 (ko) | 2005-02-14 | 2005-02-14 | 산 불안정성 약리활성물질 함유 장용성 경구용 제제 및 이의 제조방법 |
US10/596,187 US20070269509A1 (en) | 2005-02-14 | 2006-02-08 | Enteric Coated Pharmaceutical Oral Formulations Comprising Acid-Labile Active Substances, and a Method Thereof |
PCT/KR2006/000459 WO2006085723A1 (en) | 2005-02-14 | 2006-02-08 | The enteric coated pharmaceutical oral formulations comprising acid-labile active substances, and a method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050012104A KR100570446B1 (ko) | 2005-02-14 | 2005-02-14 | 산 불안정성 약리활성물질 함유 장용성 경구용 제제 및 이의 제조방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100570446B1 true KR100570446B1 (ko) | 2006-04-12 |
Family
ID=36793274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050012104A KR100570446B1 (ko) | 2005-02-14 | 2005-02-14 | 산 불안정성 약리활성물질 함유 장용성 경구용 제제 및 이의 제조방법 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20070269509A1 (ko) |
KR (1) | KR100570446B1 (ko) |
WO (1) | WO2006085723A1 (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012518655A (ja) * | 2009-02-23 | 2012-08-16 | アプタリス ファーマテック インコーポレイテッド | プロトンポンプ阻害剤を含む制御放出組成物 |
CA2910865C (en) | 2014-07-15 | 2016-11-29 | Isa Odidi | Compositions and methods for reducing overdose |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2189699A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated acid-labile medicaments |
SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
US6602522B1 (en) * | 1997-11-14 | 2003-08-05 | Andrx Pharmaceuticals L.L.C. | Pharmaceutical formulation for acid-labile compounds |
IL130602A0 (en) * | 1999-06-22 | 2000-06-01 | Dexcel Ltd | Stable benzimidazole formulation |
CA2469427A1 (en) * | 2004-06-01 | 2005-12-01 | Pharmascience Inc. | Dry mixed dosage form containing benzimidazole derivatives |
-
2005
- 2005-02-14 KR KR1020050012104A patent/KR100570446B1/ko active IP Right Grant
-
2006
- 2006-02-08 WO PCT/KR2006/000459 patent/WO2006085723A1/en active Application Filing
- 2006-02-08 US US10/596,187 patent/US20070269509A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20070269509A1 (en) | 2007-11-22 |
WO2006085723A1 (en) | 2006-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5626875A (en) | Stabilized galenic formulations comprising an acid labile benzimidazole compound and its preparation | |
CA2109697C (en) | Oral-administration forms of a medicament containing pantoprazole | |
EP1185254B1 (en) | Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same | |
CA2323536C (en) | Pharmaceutical formulation comprising a 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazole having anti-ulcer activity and a process for the preparation of such formulation | |
EP0502556B1 (en) | Use of specific core material and layers to obtain pharmaceutical formulations stable to discolouration of acid labile compounds | |
EP1213015B1 (en) | Oral pharmaceutical composition with delayed release of proton pump inhibitors | |
US8865212B2 (en) | Stable pharmaceutical formulation of an acid labile compound and process for preparing the same | |
US20040213847A1 (en) | Delayed release pharmaceutical compositions containing proton pump inhibitors | |
IL121652A (en) | Pharmaceutical dosage forms for oral administration that include a proton pump inhibitor and a prokinetic substance | |
SK286625B6 (sk) | Farmaceutický prípravok na báze omeprazolu | |
US20130216617A1 (en) | Pharmaceutical compositions of (r)-lansoprazole | |
EP0768872A1 (en) | New oral pharmaceutical formulation containing magnesium salt of omeprazole | |
KR100570446B1 (ko) | 산 불안정성 약리활성물질 함유 장용성 경구용 제제 및 이의 제조방법 | |
EP2345408A2 (en) | Acid labile drug formulations | |
US20030228363A1 (en) | Stabilized pharmaceutical compositons containing benzimidazole compounds | |
EP1785135A1 (en) | New stabilized galenic formulations comprising lansoprazole and their preparation | |
WO2003103638A1 (en) | Stabilized pharmaceutical compositions containing benzimidazole compounds | |
US20110207779A1 (en) | Process for the preparation of esomeprazole magnesium | |
AU695723C (en) | New oral pharmaceutical formulation containing magnesium salt of omeprazole | |
KR20070020977A (ko) | 판토프라졸 함유 경구용 약제 제형 | |
HRP920855A2 (en) | Pharmaceutical formulations of acid labile substances for oral use | |
IL139894A (en) | Stable benzimidazole composition and a method for producing it | |
MXPA00008985A (en) | Solid oral pharmaceutical formulation of modified release that contains an acid labile benzimidazole compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130405 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140407 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160406 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170406 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180406 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190408 Year of fee payment: 14 |